Gabapentin (GBP) is an anticonvulsant that acts at the α2δ-1 submit of the L-type calcium channel. It is recently reported that GBP is a potent inhibitor of thrombospondin (TSP)-induced excitatory synapse formation in vitro and in vivo. Here we studied effects of chronic GBP administration on epileptogenesis in the partial cortical isolation ("undercut") model of posttraumatic epilepsy, in which abnormal axonal sprouting and aberrant synaptogenesis contribute to occurrence of epileptiform discharges. Results showed that 1) the incidence of evoked epileptiform discharges in undercut cortical slices studied 1 day or~2 weeks after the last GBP dose, was significantly reduced by GBP treatments, beginning on the day of injury; 2) the expression of GFAP and TSP1 protein, as well as the number of FJC stained cells was decreased in GBP treated undercut animals; 3) in vivo GBP treatment of rats with undercuts for 3 or 7 days decreased the density of vGlut1-PSD95 close appositions (presumed synapses) in comparison to saline treated controls with similar lesions;4) the electrophysiological data are compatible with the above anatomical changes, showing decreases in mEPSC and sEPSC frequency in the GBP treated animals. These results indicate that chronic administration of GBP after cortical injury is antiepileptogenic in the undercut model of post-traumatic epilepsy, perhaps by both neuroprotective actions and decreases in excitatory synapse formation. The findings may suggest the potential use of GBP as an antiepileptogenic agent following traumatic brain injury.
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Severe traumatic brain injury is a significant risk factor for development of epilepsy that often becomes clinically apparent after a latent period of months to years (Annegers et al., 1998; Salazar et al., 1985) . Unfortunately, a large percentage of patients with symptomatic epilepsies due to trauma or other etiologies are not seizure free on appropriate pharmacological antiseizure treatment (Kwan and Brodie, 2000) . The high incidence of epileptogenesis following severe injury in war time (Salazar et al., 1985) and the expected marked increase due to the conflicts in Iraq and Afghanistan, emphasize the importance of developing prophylactic strategies that might be applied during the latent period between injury and the onset of seizures (Garga and Lowenstein, 2006) . To date, multiple clinical trials aimed at prevention of epilepsy after traumatic brain injury (TBI) with older antiseizure agents (Glötzner et al., 1983; Temkin et al., 1990 Temkin et al., , 1999 Young et al., 1983a, b) , glucocorticoids (Watson et al., 2004) and magnesium (Temkin et al., 2007) have been unsuccessful (see Temkin, 2001 , 2009 for reviews).
In previous experiments, we used the partial cortical isolation ("undercut" or "UC") model of chronic posttraumatic epileptogenesis (Echlin, 1959; Sharpless and Halpern, 1962) to assess cellular mechanisms that might underlie injury-induced focal cortical hyperexcitability (Faria and Prince, 2010; Hoffman et al., 1994; Jin et al., 2006 Jin et al., , 2011 Li and Prince, 2002; Salin et al., 1995; Tseng and Prince, 1993; reviewed in Graber and Prince, 2006; Li et al., 2011; Prince et al., 2009; Prince et al., 2012) . Rodent in vitro slices from the undercut (UC) cortex generate spontaneous and evoked epileptiform discharges after a latent period of~7-14 days (Hoffman et al., 1994; Salin et al., 1995; Tseng and Prince, 1993) . Focal suppression of cortical activity with tetrodotoxin (TTX) during a critical period of 3 days after injury reduces subsequent epileptogenesis in this model, providing a proof in principle that prophylaxis of posttraumatic epileptogenesis is possible (Graber and Prince, 1999, 2004) . The mechanisms for this effect have not been fully explored; however, recent data indicate that TTX treatment reduces immunocytochemical evidence for axonal and terminal sprouting (Prince et al., 2009) .
Enhanced excitatory connectivity is a prominent pathophysiological alteration in injured epileptogenic neocortex (Jin et al., 2006; Li and Prince, 2002; Salin et al., 1995) and hippocampus (McKinney et al., 1997; Tauck and Nadler, 1985; Yang et al., 1995) , as well as in human epileptogenic temporal lobes (Babb et al., 1991 (Babb et al., , 1992 Isokawa et al., 1993; Marco and DeFelipe, 1997; Masukawa et al., 1992) . Layer V excitatory pyramidal (Pyr) neurons in UC neocortex develop elaborate sprouting of axonal arbors with increased branching and a higher density of boutons on their axons (Salin et al., 1995) , and whole cell recordings from these cells show an increase in the frequency of spontaneous Neurobiology of Disease 48 (2012) [429] [430] [431] [432] [433] [434] [435] [436] [437] [438] 
